Replies to post #33751 on DD Support Board and Research Team

[machiavelli01]

IMDS R/S 1-500 Sch 14C 1 voter

Thanks monda, pulled story off Toxic Filings and didn't see the symbol attached. I was checking SRGE and wondered why it wasn't showing the story. Still bit dizzy from Sandy.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14C INFORMATION

http://www.sec.gov/Archives/edgar/data/790652/000079065212000043/pre14c_103012.htm

THIS INFORMATION STATEMENT IS BEING PROVIDED TO
YOU BY THE BOARD OF DIRECTORS OF IMAGING DIAGNOSTIC SYSTEMS, INC.

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE
REQUESTED NOT TO SEND US A PROXY

Imaging Diagnostic Systems, Inc.
5307, NW 35th Terrace
Fort Lauderdale, FL 33309
[phone]

INFORMATION STATEMENT
(Preliminary)

October 30, 2012

NOTICE OF STOCKHOLDER ACTION BY WRITTEN CONSENT

GENERAL INFORMATION

To the Holders of Common Stock of Imaging Diagnostic Systems, Inc.:

This Information Statement has been filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), to the holders (the "Stockholders") of common stock, no par value per share (the "Common Stock"), of Imaging Diagnostic Systems, Inc., a Florida corporation (the "Company"), to notify the Stockholders that on October 30, 2012, the Company received a unanimous written consent in lieu of a meeting of the holders of Series Q Preferred Stock, no par value per share (the "Series Q Preferred"), created by unanimous written consent of the Board of Directors of the Company (the "Board"), as permitted by the Company's Certificate of Incorporation, as may be amended (the "Certificate"). Each share of Series Q Preferred has the equivalent of 168,395,349 votes of Common Stock (based upon the outstanding number of shares of Common Stock issued at the time hereof). Currently, there is one holder of Series Q Preferred (the "Series Q Stockholder" or the "Majority Stockholder"), holding fifty-one (51) shares of Series Q Preferred, resulting in the Series Q Stockholder holding in the aggregate approximately 50.9989% of the total voting power of all issued and outstanding voting capital of the Company. The Series Q Stockholder authorized the following:
·
The 1-for-500 reverse stock split of the Company's issued and outstanding shares of Common Stock (the "Reverse Stock Split");

On October 30, 2012, the Board approved the Reverse Stock Split and recommended to the Majority Stockholder that she approve the Reverse Stock Split. On October 30, 2012, the Majority Stockholder approved the Reverse Stock Split by written consent in lieu of a meeting, in accordance with Florida law. Accordingly, your consent is not required and is not being solicited in connection with the approval of the Reverse Stock Split.

We will mail the Notice of Stockholder Action by Written Consent to the Stockholders on or about November 9, 2012.

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND A PROXY.